<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04208256</url>
  </required_header>
  <id_info>
    <org_study_id>19-1171</org_study_id>
    <nct_id>NCT04208256</nct_id>
  </id_info>
  <brief_title>Food Intake and the Adolescent Brain</brief_title>
  <official_title>The Neural Underpinnings of Disinhibited Eating Behavior in Adolescents With and Without Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The brain plays an integral role in how and what people eat. However, the brain's
      contribution to overeating is not well understood during sensitive developmental periods such
      as adolescence, when excessive weight gain and obesity prevalence are a significant
      concern.The proposed study will use functional magnetic resonance imaging to examine how the
      brain's response to excess energy is related to overeating in adolescents with and without
      obesity.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 21, 2020</start_date>
  <completion_date type="Anticipated">September 2025</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain function</measure>
    <time_frame>brain imaging visit 1 (study visit 1); 30 minutes</time_frame>
    <description>Brain function will be quantified via the blood oxygen level-dependent (BOLD) signal in the hypothalamus, insula, anterior cingulate cortex, nucleus accumbens, amygdala, and superior and inferior frontal gyri, and connectivity between these brain regions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disinhibited eating behavior</measure>
    <time_frame>study visit 2; 1.5 hours</time_frame>
    <description>Disinhibited eating behavior will be quantified via the kilocalories consumed during the test meal phase of the Eating in the Absence of Hunger laboratory protocol.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pediatric Obesity</condition>
  <arm_group>
    <arm_group_label>Energy Neutral</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Bottled water (300 ml) with added fruit punch-flavored non-nutritive sweetener (aspartame) will be used as the energy neutral stimulus.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Energy Surplus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>300ml fruit punch-flavored Glucola (75-gram[g], Azer Scientific) will be used as the energy surplus stimulus.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Energy Stimulus</intervention_name>
    <description>Energy stimulus (energy surplus v. energy neutral) will be randomly assigned at the first brain imaging visit. At the second brain imaging visit, the participant will receive the alternate stimulus from what they received at the first brain imaging visit.</description>
    <arm_group_label>Energy Neutral</arm_group_label>
    <arm_group_label>Energy Surplus</arm_group_label>
    <other_name>aspartame</other_name>
    <other_name>Glucola</other_name>
    <other_name>glucose</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female

          -  13-18 years-old

          -  resident of Colorado

        Exclusion Criteria:

          -  weigh less than 88 pounds or have a BMI% rank of &lt;10% for age and sex;

          -  have a physician's diagnosis of metabolic syndrome or diabetes (Type 1 or 2);

          -  have a physician's diagnosis of anorexia nervosa or bulimia nervosa;

          -  currently taking anti-psychotic medications (not including anti-depressant or anti-
             anxiety medications);

          -  have a non-MRI safe device (e.g. pacemaker or defibrillator) or metal in the body
             (e.g. metal pins, shrapnel);

          -  experience symptoms of claustrophobia when in small or closed-off places;

          -  are pregnant or plan to become pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Shapiro, PhD</last_name>
      <phone>303-724-3733</phone>
      <email>allison.shapiro@cuanschutz.edu</email>
    </contact>
    <investigator>
      <last_name>Allison Shapiro, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Tregellas, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susan Johnson, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc Cornier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 19, 2019</study_first_submitted>
  <study_first_submitted_qc>December 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2019</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pediatric obesity</keyword>
  <keyword>resting-state functional magnetic resonance imaging</keyword>
  <keyword>disinhibited eating behavior</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

